Coronavirus - Overall
-
@Frank said in Coronavirus - Overall:
Dr Trump.
Hydroxychloroquine helped save coronavirus patients, study shows; Trump campaign hails 'fantastic news'. Drug touted by Trump was mocked by media
His actions were still irresponsible. Leave drug advice to the experts. It appears to be useful in a very narrow mode of application. Doesn't help if people end up trying to snap up the drug and it actually harms those who aren't already infected and about to get very sick
-
@Frank said in Coronavirus - Overall:
Dr Trump.
Hydroxychloroquine helped save coronavirus patients, study shows; Trump campaign hails 'fantastic news'. Drug touted by Trump was mocked by media
And yet WHO have now suspended trials of hydroxychloroquine. Who to believe?
-
What the fuck is wrong with people in the US? Have they totally lost their minds?
-
In our defense, according to that article, neither entity that investigated found any evidence it's actually happening. It wouldn't surprise me, but in a country this big, you're always going to find some idiots.
We're seeing a small surge in my county. It's centered around attendance at one church, and the families of the firefighters at one firehouse.
I could write a book on covid in the U.S. and why it's so much more complicated, but this quote from the article sums it up for me:
"The sheer size of the US and how the virus was spreading to different parts of the country at different times, complicated the public response when compared with other countries."
It's like if you put all of Europe together and treated it like it's a monolith. That's what some politicians and policymakers have tried to do and now it's backfiring on them.
-
@Catogrande said in Coronavirus - Overall:
patients, study shows; Trump campaign hails 'fantastic news'. Drug touted by Trump was mocked by media
You can check for yourself:
-
@photo-fox said in Coronavirus - Overall:
In our defense, according to that article, neither entity that investigated found any evidence it's actually happening. It wouldn't surprise me, but in a country this big, you're always going to find some idiots.
We're seeing a small surge in my county. It's centered around attendance at one church, and the families of the firefighters at one firehouse.
I could write a book on covid in the U.S. and why it's so much more complicated, but this quote from the article sums it up for me:
"The sheer size of the US and how the virus was spreading to different parts of the country at different times, complicated the public response when compared with other countries."
It's like if you put all of Europe together and treated it like it's a monolith. That's what some politicians and policymakers have tried to do and now it's backfiring on them.
Are you in Santa Barbara by any chance?
-
@photo-fox Good post. A regular tactic from certain outlets comparing say Sweden or NZ to the USA to make some ridiculous point or mainstream press taking a few isolated tweets and framing them as opinion of a large section of society.
-
@Catogrande
It's pretty obvious that the problem with hydroxychloroquine is political, not science.
I've been following this since March, it should have been widely used and publicised for immediate use for outpatients exhibiting minor sympoms.Hydroxychloroquine lowers COVID-19 death rate, Henry Ford Health study finds
-
@Catogrande Reading through the whole article (about Michigan hospitals stopping using it), linked therein, shows few actual facts against HCQ, and that it was not used in the manner people have been pushing for-outpatient use combined with zinc and azithromycin (although it is less important). When administered immediately upon manifestation of symptoms, it has shown excellent results.
People that are admitted to hospital, and/or suffering ARDS, would be less likely to benefit from hydroxychloroquine, but many still do recover amazingly quickly-it would be on a case by case basis dependent on the patient's health. Most studies have been focused on the hospital setting. -
using the link I pasted above, https://c19study.com/, the first 9 (out of many studies shown (about 44 back to the start of May, almost all positive)...shown below quoted and abridged for clarity:
Global HCQ studies. PrEP, PEP, and early treatment studies show high effectiveness, while late treatment shows mixed results.*7/3 Positive Lancent Rheumatology, (Peer Reviewed) COVID-19 in patients with rheumatic disease in Hubei province, China:
Rheumatic disease patients on HCQ had a lower risk of COVID-19 than those on other disease-modifying anti-rheumatic drugs,7/3 Positive Scholz et al., COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin:
Early treatment with HCQ+AZ+Z results in 84% lower hospitalization and 80% lower death. No cardiac side effects. Retrospective 518 patients (141 treated, 377 control).7/1 Positive Arshad et al. (Peer Reviewed) Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
HCQ decreases mortality from 26.4% to 13.5% (HCQ) or 20.1% (HCQ+AZ). Michigan 2,541 patients retrospective. Differences in age and sex between HCQ and untreated groups may favor the treatment and the control respectively.6/30 Positive Mikami et al. (Peer Reviewed) Risk Factors for Mortality in Patients with COVID-19 in New York City
HCQ decreases mortality, Retrospective 6,000 patients in New York City.6/29 Positive Ferreira et al., (Preprint) Chronic treatment with hydroxychloroquine provides protection against COVID, ...the actual benefit may be significantly higher .
6/25 Positive Lagier et al. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France:
Early treatment leads to significantly better clinical outcome and faster viral load reduction. Retrospective 3,737 patients.6/22 In Vitro Wang et al. (not included in the study count) Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of COVID-19
6/22 Positive Chen et al. (Preprint) Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study......Significantly faster clinical recovery and shorter time to RNA negative (from 7.0 days to 2.0 days (HCQ), 67 patients with mild/moderate cases.
6/19 Positive (news) SMSH Sawai Man Singh Hospital, India (not included in the study count) HCQ beneficial as preventive drug: SMS doctors told ICMR
PrEP with 4,300 very high risk healthcare workers in a hospital with up to 500+ COVID patients at a time, only 1% cases, all recovered.*